CHARTS: LINE | PIE | COLUMN | TOP 25 | Classifications | 483 Reverse Lookup |
Warning Letters | Regulatory Action Reports | OpenFDA: CAERs | Recalls |


Note that as of FDA FY 2018, this chart is now compiled from new FDA Citations spreadsheets. The previous chart based on FDA observations data can be found archived here.

* Partial Fiscal Year data (since 10/1)
This chart indicates the total number of observations by fiscal year found during FDA inspections of dietary supplement companies under 21 CFR 111 cGMPs for the most frequently cited observations.


DISCLAIMER: These charts are compiled from FDA data. The author does not guarantee that all information provided is accurate and complete, as FDA may redact certain information from the published datasets. Please confirm your conclusions by checking at the FDA web site: Inspection Classifications and  Inspection Observations or make a FOI request to FDA. I will be glad to make a FOI request on your behalf, please contact me.


All charts and tables are ©2017 Marian Boardley Consulting LLC. If you found this information useful, please consider making a $5 contribution (suggested) at paypal.me/MarianBoardley. Thank You!